Alzheimers | Australian Biotech Company News

Home Tags Alzheimers

Biotechnology

Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M

BioChannel - March 24, 2020

Biotechnology

Alzheimer’s Disease Protein Clearance Mechanism Identified

BioChannel - February 19, 2020

Biotechnology

Trial Triumphs, Takeover Talk Boost Reata Pharmaceuticals

BioChannel - February 10, 2020

Biotechnology

EU Project Set up to Fight Alzheimer’s Disease with Lasers

BioChannel - February 7, 2020

Biotechnology

In Alzheimer’s, New Protein Is Seen at Heart of Plaque Formation

BioChannel - January 22, 2020

Biotechnology

Neurodegenerative Treatments Build to a Tipping Point

BioChannel - January 17, 2020

Biotechnology

Biogen Shares Surge after Reversal on Alzheimer’s Candidate Aducanumab

BioChannel - October 22, 2019

Biotechnology

It’s News Roundup Time! Cheap Vaccines, Genomics and More …

BioChannel - October 4, 2019

Biotechnology

Lilly Making First Milestone Payment in $1.9B Collaboration with AC Immune

BioChannel - September 20, 2019

Biotechnology

Alzheimer’s Disease Shows Up Early as Retinal Thinning and Thickening

BioChannel - September 16, 2019

12 Page 1 of 2

Stay connected

Recent posts

ACM Prize in Computing awarded to AlphaGo developer

BioChannel - April 1, 2020

Putting COVID-19 on the ‘Map’

BioChannel - March 31, 2020

Update: AM-Pharma Increases Acute Kidney Injury Phase III Funds to €163M

BioChannel - March 31, 2020

Random article

ACM Prize in Computing awarded to AlphaGo developer

Putting COVID-19 on the ‘Map’

Update: AM-Pharma Increases Acute Kidney Injury Phase III Funds to €163M

Unlocking The Power Of Expert Analytics